6.00
+0.01(+0.17%)
Currency In USD
| Previous Close | 5.99 |
| Open | 6 |
| Day High | 6 |
| Day Low | 6 |
| 52-Week High | 1,200 |
| 52-Week Low | 5.37 |
| Volume | 38,694 |
| Average Volume | 473,366 |
| Market Cap | 45.34M |
| PE | 0 |
| EPS | -12,356.89 |
| Moving Average 50 Days | 10.83 |
| Moving Average 200 Days | 269.6 |
| Change | 0.01 |
If you invested $1000 in Helius Medical Technologies, Inc. (HSDT) 10 years ago, it would be worth $0 as of August 23, 2025 at a share price of $6. Whereas If you bought $1000 worth of Helius Medical Technologies, Inc. (HSDT) shares 5 years ago, it would be worth $0.01 as of August 23, 2025 at a share price of $6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
GlobeNewswire Inc.
Jul 21, 2025 11:00 AM GMT
NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced positive outcome
Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements
GlobeNewswire Inc.
Jul 09, 2025 12:30 PM GMT
NEWTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, toda
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
GlobeNewswire Inc.
Jun 16, 2025 11:00 AM GMT
- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated price